Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis by Yu-Chuan Lu et al.
RESEARCH ARTICLE Open Access
Predictors of failure of conservative treatment
among patients with emphysematous
pyelonephritis
Yu-Chuan Lu1, Bing-Juin Chiang1, Yuan-Hung Pong1, Kuo-How Huang1, Po-Ren Hsueh2, Chao-Yuan Huang1*
and Yeong-Shiau Pu1
Abstract
Background: Emphysematous pyelonephritis (EPN) is a severe necrotizing infection of the renal parenchyma and
perirenal tissues that is caused by gas-producing bacterial pathogens. Percutaneous drainage is now the gold
standard of definitive management. The aim of this study is to analyze the predictors associated with failure of
conservative treatment among patients with EPN and offer the recommendation of appropriate empirical antibiotic
regimen.
Methods: From January 2001 to December 2013, 44 consecutive patients were diagnosed with EPN. The
demographic characteristics, clinical presentations, management strategies, and final outcomes were analyzed
retrospectively.
Results: The overall survival rate was 88.6% (39/44). Need for emergency hemodialysis, shock on initial presentation,
altered mental status, severe hypoalbuminemia, inappropriate empirical antibiotic treatment and polymicrobial
infections were significantly more common in the patients who died compared with the survivors. The overall
failure rate of conservative treatment was 32.6% (14/43). Severe hypoalbuminemia (p = 0.003), need for emergency
hemodialysis (p = 0.03), and polymicrobial infections (p = 0.04) were significantly associated with failure of
conservative treatment. Severe hypoalbuminemia was independently associated with conservative management
failure (p = 0.02). Even in the patients treated with percutaneous drainage plus effective antibiotics, failure was still
associated with severe hypoalbuminemia (p = 0.01). According to the in vitro susceptibility data, third-generation
cephalosporins is recommended as the empirical antibiotic regimen.
Conclusions: Both appropriate empirical antibiotic and percutaneous drainage were essential for patients with EPN.
Patients with severe hypoalbuminemia had a higher risk of conservative treatment failure, and additional
management may be required.
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Background
Emphysematous pyelonephritis (EPN) is a severe necro-
tizing infection of the kidneys that is characterized by
bacterial production of gas within the renal parenchyma
[1]. It occurs most commonly in female diabetic patients
(70% to 90%), and has a mortality rate of up to 80% when
patients are only treated medically [1,2].
Treatment options for EPN have evolved over the years,
from invasive surgery to more conservative approaches in-
cluding percutaneous catheter drainage (PCD) or the use
of a double-J catheter (DBJ). Until the late 1980s, the
management of EPN usually involved emergency nephrec-
tomy and/or open surgical drainage with antibiotic treat-
ment [1], however this approach was associated with a
mortality rate of 40% to 50% [3]. The implementation of
PCD techniques facilitates maximum nephron sparing
and restoration of renal function [4]. Over the last two de-
cades, improvements in management techniques have re-
sulted in a decrease in the mortality rate to 21% [5].
Percutaneous drainage, rather than nephrectomy, is
now the gold standard of care and definitive manage-
ment for the majority of patients with EPN [6]. This
strategy is associated with a lower mortality rate than
medical management or emergency nephrectomy. Even
though conservative treatment is favorable, salvage neph-
rectomy or open surgical drainage is still necessary in a
small proportion of patients. However, there is limited in-
formation about the usefulness of clinical parameters to
classify patients who are likely to fail conservative treat-
ment. This retrospective study aimed to determine the
factors that may predict the failure of conservative treat-
ment in patients with EPN.
Methods
This study was approved by the Institutional Review Board
and Ethics Committee of National Taiwan University
Hospital. Forty-four consecutive patients with EPN were
treated at the National Taiwan University Hospital from
January 2001 to December 2013. Information on clinical
and demographic profiles including age, sex, underlying
medical conditions, laboratory investigations, clinical fea-
tures at initial presentation, imaging studies, type of man-
agement, and outcomes of the patients were obtained from
medical charts. The clinical features included signs and
symptoms at presentation, and the patients’ hemodynamic
and mental status. The laboratory variables included white
blood cell count, platelet count, C-reactive protein, serum
albumin, serum sodium, hemoglobin A1C (HbA1C), and
serum creatinine, as well as the results of urinalysis and
blood, wound, and urine cultures, mostly obtained at
the initial presentation. The initial management modalities
for EPN consisted of antibiotics alone, PCD with antibi-
otics, an indwelling double-J catheter with antibiotics and
emergency nephrectomy. Conservative treatment of EPN
comprised antibiotics alone and PCD or an indwelling
double-J catheter with antibiotics. Appropriate empirical
antibiotic treatment had to be treatment matching the
in vitro susceptibility of the pathogens.
Definitions
According to the classification system of Huang and Tseng
[7], which is based on the extent of air seen on computed
tomography (CT), the patients were divided into one of the
following five EPN classifications: class 1, gas in the collect-
ing system only; class 2, gas in the renal parenchyma with-
out extension to the extrarenal space; class 3A, extension of
gas or abscess to the perinephric space; class 3B, extension
of gas or abscess to the pararenal space; and class 4, bilat-
eral EPN or a solitary kidney with EPN. Thrombocytopenia
was defined as a platelet count less than 120,000/mL, se-
vere hypoalbuminemia as serum albumin < 3.0 g/dL, and
hyponatremia as serum sodium < 135 mEq/L. Shock was
defined as a systolic pressure less than 90 mmHg and
evidence of end organ damage including the respiratory
system, liver, or kidneys. The patients with an absolute in-
crease in serum creatinine of ≥ 0.3 mg/dL after admission
compared with baseline were diagnosed with acute kidney
injury. Recurrent EPN was diagnosed when both a clinical
presentation of sepsis and progressive lesions on imaging
studies were noted within three months after adequate
treatment for EPN.
We defined success of conservative treatment as im-
provement in clinical condition, decrement of air distribu-
tion in follow-up images, and discharge alive after PCD,
DBJ indwelling or antibiotics alone. Failure of conservative
treatment was defined as intra-hospital mortality, recur-
rent EPN, or appearance of unstable hemodynamics or a
prolonged fever after conservative treatment within seven
days. Salvage nephrectomy or open drainage was per-
formed if conservative treatment failed.
Statistical analysis
Categorical variables were compared using the chi-square
test or Fisher’s exact test. Continuous variables were
expressed as median values, and the Wilcoxon rank sum
test was used for comparisons. The independent variables
with a p-value ≤ 0.05 in the univariate analysis were se-
lected for logistic regression analysis to identify the inde-
pendent factors significantly associated with occurrence
of conservative treatment failure. A p-value of ≤ 0.05 was
considered to be statistically significant.
Results
The mean (standard deviation) age of the patients was 59.9
(15.5) years. There were 32 women (72.7%) and 12 men.
Thirty patients (68.2%) had type II diabetes mellitus, and
obstructive uropathy was the second most common pre-
disposing factor (23 patients, 52.3%). Urolithiasis occurred
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in half of the patients. Other comorbidities included
hypertension (17 patients, 38.6%), cerebrovascular acci-
dents (5 patients, 11.4%), liver cirrhosis (4 patients, 9.1%),
Down syndrome (1 patient, 2.3%), and acquired immuno-
deficiency syndrome (1 patient, 2.3%). The left kidney
was more frequently affected than the right (28 vs. 18);
2 patient had bilateral involvement and 2 had EPN of a
solitary kidney. Table 1 demonstrates the clinical and
epidemiological characteristics of the surviving and
non-surviving patients.
Shock occurred in 9 patients, and 15 patients had altered
mental status upon initial presentation. Acute kidney injury
was noted in 22 patients. Five patients underwent emer-
gency hemodialysis, 3 of whom died. The mean leukocyte
count at admission was 15286/μL. Thrombocytopenia and
hypoalbuminemia were present in 11 (25%) and 22 (50%)
Table 1 Demographic data and clinical characteristics of the patients with emphysematous pyelonephritis
Variable, n (%) Surviving (n = 39) Died (n = 5) P-value OR P-value
Median age (y) 60 65 0.32 1. (0.9-1.1) 0.40
Female sex 27 (69.2) 5 (100) 0.30 - -
Underlying condition
Diabetes mellitus 27 (69.2) 3 (60) 0.65 0.7 (0.1-4.5) 0.68
Hypertension 14 (35.9) 3 (60) 0.36 2.7 (0.4-18) 0.31
Prior cerebrovascular accident 4 (10.3) 1 (20) 0.47 2.2 (0.2-24.7) 0.53
Down syndrome 1 (2.6) 0 (0) 1.00 - -
Liver cirrhosis 3 (7.7) 1 (20) 0.39 3 (0.3-36.1) 0.39
Obstructive uropathy 19 (48.7) 4 (80) 0.35 4.2 (0.4-41.1) 0.22
Urolithasis 19 (48.7) 3 (60) 1.00 1.6 (0.2-10.5) 0.64
Laboratory finding
Leukocyte (103/μL) 13.8 15.40 0.77 1.0 (0.9-1.1) 0.83
Platelet count (103/mL) 195.0 106.0 0.08 0.9 (0.8-1.0) 0.15
Thrombocytopenia 8 (20.5) 3 (60) 0.09 5.8 (0.8-40.9) 0.08
(≤120,000/mL)
Albumin (g/dL) 2.7 2.8 0.43 0.4 (0.1-2.5) 0.36
Hypoalbuminemia 17 (47.2) 5 (100) 0.05 - -
(<3.0 g/dL)
Hyponatremia 10 (25.6) 2 (40) 0.60 1.9 (0.3-13.3) 0.50
C-reactive Protein (mg/dL) 9.2 5.98 0.67 1.0 (0.9-1.1) 0.68
Pyuria 32 (88.9) 5 (100) 1.00 - -
Hematuria 21 (58.3) 5 (100) 0.14 - -
HbA1C >8% 17 (47.2) 2 (40) 1.00 0.7 (0.1-5.6) 0.73
Image study
Radiologic classification 21 (56.8) 1 (20) 0.17 0.2 (0.02-2.3) 0.22
(3A,3B,4)a
Involved site (left) 23 (59.0) 3 (60) 1.00 0.9 (0.1-6.3) 0.95
Bilateral involvement 2 (5.1) 0 (0) 1.00 - -
Need for hemodialysis 2 (5.1) 3 (60) 0.01 27.8 (2.8-272.9) 0.004
Inappropriate empirical antibiotic use 3 (8.6) 3 (60) 0.02 16.0 (1.9-136.7) 0.01
Bacteremia 16 (41.0) 4 (80) 0.16 5.8 (0.6-56.4) 0.13
Shock 5 (12.8) 4 (80) 0.004 27.2 (2.5-295.0) 0.01
Acute kidney injury 18 (46.2) 4 (80) 0.35 4.7 (0.5-45.6) 0.19
Altered mental status 11 (28.2) 4 (80) 0.04 10.2 (1.0-101.5) 0.05
Polymicrobial infection 7 (18.0) 5 (100) 0.001 - -
aRadiologic classification is based on the extent of air seen on computed tomography (CT): class 3A, extension of gas or abscess to the perinephric space; class 3B,
extension of gas or abscess to the pararenal space; class 4, bilateral EPN or a solitary kidney with EPN.
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patients, respectively. Eight patients had class 1 EPN, 12
had class 2, 11 had class 3A, 7 had class 3B (Figure 1), and
4 had class 4 based on CT imaging findings; CT data were
missing for 2 patients.
Third-generation cephalosporin (18/44, 40.9%) were most
often prescribed initially to the patients. Antibiotics were
adjusted after available blood, urine or pus cultures. Escher-
ichia coli was the most common causative organism cul-
tured from urine, blood or wound specimens, present in 21
(47.7%) patients. The other organisms isolated included
Proteus mirabilis (20.5%), Klebsiella pneumoniae (15.9%),
Enterococcus species (15.9%), Pseudomonas aeruginosa
(11.4%), and Candida species (11.4%). Polymicrobial infec-
tions were found in 12 patients (27.3%). Urine cultures
were positive in 33 patients, and 19 patients had E. coli in-
fections. Bacteremia occurred in 20 patients (43.9%), with
E. coli bacteremia in 12 patients. Cultures of wound pus
were positive in 21 patients, with E. coli in 10, P. mirabilis
in 7, and K. pneumoniae in 3 (Table 2). Table 3 showed the
in vitro susceptibility of the causative pathogens.
The overall survival rate was 88.6% (39/44). Need for
emergency hemodialysis (p = 0.01), shock on initial presen-
tation (p = 0.004), altered mental status (p = 0.04), severe
hypoalbuminemia (p = 0.05), and inappropriate empir-
ical antibiotic treatment (p = 0.02) and polymicrobial
infections (p = 0.001) were significantly more common
in the non-survivors than in the survivors. There were no
significant differences between the non-survivors and sur-
vivors with regard to age, history of diabetes mellitus,
thrombocytopenia, acute kidney injury, serum creatinine
level, leukocyte count, presence of microscopic hematuria,
pyuria, urinary tract obstruction, or urolithiasis.
Ten patients received antibiotics alone, and treatment
was successful in 80.0% of these patients (2 patients died).
Third-generation cephalosporins were the most frequently
used antibiotics and were used in 7 patients (for cases
caused by E. coli or P. mirabilis). One patient underwent
emergency nephrectomy and survived. One patient under-
went ureteroscopy with double-J catheter stenting and
survived. Thirty-two patients were treated with PCD and
antibiotics, 20 of whom did well (Figure 2). However, 8 pa-
tients experienced recurrent EPN within 3 months, and
3 patients died thereafter. Persistent fever was noted in
4 patients after PCD. Overall, 5 patients received salvage
nephrectomy, 1 underwent open drainage and 1 required
repeated PCD. Elective nephrectomy was carried out in
2 patients with poorly functioning kidneys. The overall
failure rate of conservative therapy was 32.6% (14/43).
Severe hypoalbuminemia (p = 0.003), need for emer-
gency hemodialysis (p = 0.03), and polymicrobial infec-
tions (p = 0.04) were significantly associated with failure of
conservative treatment (Table 4). Table 5 shows the results
of multivariate analysis of the three significant variables, in
which severe hypoalbuminemia was independently associ-
ated with failure of conservative therapy (p = 0.02).
Among the 32 patients who received PCD, treatment
failed in 12. Only severe hypoalbuminemia had association
with PCD failure (p = 0.01). The patients with hypoalbu-
minemia had a significantly higher incidence of conserva-
tive therapy failure (57.1%) and PCD failure (55.6%).
Discussion
A high level of awareness is required for patients with
EPN due to the life-threatening nature of the associated
septic complications. Treatment of EPN initially involves
fluid and electrolyte resuscitation, antibiotic therapy, gly-
cemic control, and relief of urinary tract obstruction where
appropriate. Further management consists of either con-
servative medical treatment with antibiotics, emergency
nephrectomy with medical therapy, or PCD with medical
therapy. The treatment of EPN has evolved over the years
from invasive surgery to more conservative approaches.
Some studies advocate nephrectomy for patients with EPN,
in combination with antibiotics, fluids, and optimization
of blood glucose and electrolytes [3,8]. However, the mor-
tality rate in a series by Ahlering et al. advocating emer-
gency nephrectomy was 42% [3]. Some specialists have
proposed that conservative treatment or PCD should only
Figure 1 Contrast CT revealed the presence of gas in the left pelvicalyceal system with extending into paranephric area (Class 3B).
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be used for select cases such as localized EPN, bilateral
disease, EPN in a solitary kidney, or if the patient cannot
tolerate general anesthesia [9]. Medical treatment with an-
tibiotics alone carries the highest risk of mortality [1].
However, in the current study, 10 patients received antibi-
otics alone, and the mortality rate was 20% (2 patients
died). Most of the cases in the current study were limited
EPN (class 1 & 2) and were comparatively healthy. Six pa-
tients had class 1 EPN, 3 had class 2, and 1 had class 3A
with a small air pocket. This may account for the superior
outcomes compared with prior studies. Thirty-two pa-
tients underwent PCD plus antibiotics, and 3 patients
(9.4%) eventually died. In a meta-analysis of management
strategies, the mortality rate with medical treatment alone
was 50%, and for PCD plus medical treatment the mortal-
ity rate was 13.5% [5]. The reported mortality rate with
PCD is consistent with our results. However, in our study,
8 patients experienced recurrent EPN, and 4 patients had
persistent fever after PCD. The failure rate of PCD was
37.5%.








E. coli (19) E. coli (10) E. coli (12) E. coli (21)
Polymicrobial (11) P. mirabilis (7) K. pneumoniae (3) P. mirabilis (9)
K. pneumoniae (3) Polymicrobial (1) Enterococcus species (7)
















Ampicillin 25 33.3 0 40 -
Amoxicillin 65 100 40 - -
Amikacin 100 100 100 - 80
Cefazolin 64.7 83.3 20 - -
Cefuroxime 75 100 0 - -
Cefotaxime 90 100 60 - -
Cefmetazole 88.9 100 60 - -
Ceftazidime 100 100 100 - 80
Ciprofloxacin 70.6 100 50 20 80
Levofloxacin 70 100 50 - 80
Piperacillin/tazobactam 88.2 100 75 - 75
Cefepime 95 100 100 - 60
Imipenem 100 100 100 - 100
Ertapenem 100 100 100 -
Meropenem 100 - - - 66.7
Cotrimoxazole 38.5 40 50 -
Gentamicin 70 66.7 100 - 25
Tetracycline - - - 40 -
Teicoplanin - - - 60 -
Vancomycin - - - 100 -
Linezolid - - - 100 -
Aztreonam - - - 0 80
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We then investigated the factors that were predictive of
mortality and failure of conservative treatment. To the
best of our knowledge, this is the first study to specifically
analyze the predictors associated with conservative man-
agement failure of EPN and offer the recommendation of
appropriate empirical antibiotic. It is also one of the lar-
gest studies investigating the prognostic factors of EPN.
Diabetes mellitus appeared to be the most common
risk factor for developing EPN. It is believed that a high
tissue glucose concentration may provide a favorable en-
vironment for the growth of gas-producing bacteria and
for the inhibition of leukocyte function, which then im-
pairs the response to infection [10]. Nevertheless, dia-
betes was not found to be associated with increased
mortality (p = 0.65, odds ratio [OR] = 0.67) or with fail-
ure of conservative treatment (p = 1.00, OR = 1.32) in the
present study, even among the patients with poorly con-
trolled diabetes (HbA1C > 8%). Similarly, there were no
significant associations between a higher mortality rate
in the patients with EPN and sex, age, or other comor-
bidities such as liver cirrhosis, hypertension, and history
of cerebrovascular accidents.
Serum albumin is the most abundant protein in hu-
man blood plasma and constitutes approximately half
of the blood serum proteins. Albumin transports hor-
mones, fatty acids, and other compounds, buffers blood
pH, and maintains osmotic pressure. Albumin synthesis is
suppressed in response to inflammatory conditions and
malnutrition [11]. In sepsis, infection, trauma, or major
surgery, albumin level decreases by 1–1.5 g/dl over 3–7
days. In a study of over 15,000 severely ill patients, an
admission serum albumin < 3.4 g/dl has been corre-
lated with increased of mortality [12]. Hypoalbuminemia
was found to be a strong predictor of increased mortality
and morbidity in surgical or ICU patients [13]. It has been
reported that survival after acute kidney injury is signifi-
cantly altered according to the level of serum albumin
[14]. Accelerated protein breakdown is a feature of the
metabolic alterations seen in patients with acute kidney
injury. In our previous study, severe hypoalbuminemia
(<3.0 g/dL) combined with acute kidney injury was associ-
ated with an increased mortality rate (42.9%, p = 0.03) in
patients with EPN. In the present study, severe hypoalbu-
minemia was independently associated with an increase in
the failure of conservative treatment. Even in the patients
treated with PCD plus antibiotics, the failure rate was still
independently associated with severe hypoalbuminemia.
Therefore, the patients with severe hypoalbuminemia had
Figure 2 Study cohort by outcome. Values indicate the number of patients.
Table 4 Factors associated with failure of conservative treatment





Hypoalbuminemia 9 (34.6) 12 (85.7) 0.003 11.3 (2.1-62.1) 0.01
(<3.0 g/dL)
Need for hemodialysis 1 (3.5) 4 (28.6) 0.03 11.2 (1.1-112.5) 0.04
Polymicrobial infection 5 (17.2) 7 (50) 0.04 4.8 (1.2-20.0) 0.03
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a higher risk of conservative treatment failure and add-
itional management including salvage nephrectomy, open
drainage or repeated PCD was required. Hypoalbumin-
emia is probably related to infection, however, it can also
be the result of a previous illness, such as liver cirrhosis.
When the patients with liver cirrhosis was excluded,
there was still association between PCD failure and
severe hypoalbuminemia (n = 30, p = 0.01). It is not
known whether albumin concentration itself is im-
portant or whether it is simply a marker of poor general
health. The benefit of correcting hypoalbuminemia in
this situation has not been clearly established. However,
PCD with antibiotics is still recommended in the initial
stage for the patients who have severe hypoalbuminemia,
as it immediately reduces renal tissue pressure and de-
creases the mortality rate.
In a literature review, many prognostic factors for mor-
tality were identified, however none of the trials studied a
large population. Khaira et al. [15] also reported that shock
was an independent poor prognostic risk factor in a case
series of 19 patients with EPN. Huang and Tseng [7] re-
ported that thrombocytopenia, altered mental status, se-
vere proteinuria, and acute renal failure at the presentation
of EPN were associated with a poor outcome. Similarly, a
study conducted in India of 39 patients with EPN showed
that altered mental status, thrombocytopenia, renal failure,
and severe hyponatremia at presentation were also associ-
ated with higher mortality rates [16]. In a meta-analysis,
systolic blood pressure less than 90 mmHg, serum creatin-
ine greater than 2.5 mg/dL, and impairment of conscious-
ness were also found to be associated with increased
mortality [17]. In the present study of 44 patients with
EPN, need for emergency hemodialysis, shock on initial
presentation, altered mental status, severe hypoalbu-
minemia, inappropriate empirical antibiotic regimen
and polymicrobial infections were significantly associ-
ated with mortality. With regards to the classification of
EPN based on the degree of gas seen on CT, the outcomes
of the patients with class 3 and 4 EPN were not statisti-
cally different from those with class 1 and 2 disease, which
is in agreement with previously reported studies [15]. Even
though Huang and Tseng reported a tendency towards
higher mortality and failure rates with PCD in extensive
disease (class 3 and 4) [7], we did not find this association.
The alternative approach of conservative treatment also
had no association with the failure rate (p = 0.23).
Microbial organisms cultured from the urine, kidneys
and blood of patients with EPN include the common urin-
ary pathogens, E. coli, K. pneumoniae and P. mirabilis.
In the present study, other organisms cultured consist of
P. aeruginosa and Enterococcus species. Infection by an-
aerobic organisms (for example Bacteroides fragilis and
Clostridium septicum) has also been reported [18,19]. It is
common wisdom that appropriate empirical antibiotic
treatment (i.e., matching the in vitro susceptibilities of the
isolated pathogens) reduces mortality. In EPN patient, we
also found that inadequate empirical antibiotic use was
significantly associated with mortality. The choice of
empirical antibiotic regimen should be appropriate for
targeting Gram negative bacteria. Third-generation cepha-
losporins, for example ceftazidime, is recommended as
the initial antibiotic regimen because of high susceptibil-
ity and anti-pseudomonal activity. In patients with se-
vere sepsis and septic shock, vancomycin plus imipenem
or ceftazidime as the empirical choice is suggested. How-
ever, fluoroquinolone should be avoided because of lower
susceptibility rate among common gram-negative bac-
teria in Taiwan [20]. Approximately 70% of the E. coli
isolates and 50%K. pneumoniae isolates were susceptible
to fluoroquinolones.
This study has limitations inherent to all retrospective,
single institution studies. The small number of patients
may account for the lack of significance of some of the
factors analyzed. Second, we mostly used data acquired
at the initial presentation to identify the risk factors for
mortality. Factors that varied over the time of treatment
may also have influenced outcomes. A larger prospective
cohort study is required to support our findings.
Conclusions
Severe hypoalbuminemia was associated with the failure
of conservative management and PCD. Patients with se-
vere hypoalbuminemia had a higher risk of conservative
treatment failure, and additional management may be
required for these patients.
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